These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24588905)

  • 41. Intradiscal injection therapy for degenerative chronic discogenic low back pain with end plate Modic changes.
    Cao P; Jiang L; Zhuang C; Yang Y; Zhang Z; Chen W; Zheng T
    Spine J; 2011 Feb; 11(2):100-6. PubMed ID: 20850390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis.
    Tu CW; Huang KF; Hsu HT; Li HY; Yang SS; Chen YC
    J Surg Res; 2014 Nov; 192(1):112-6. PubMed ID: 24948545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial.
    McClung M; Miller P; Recknor C; Mesenbrink P; Bucci-Rechtweg C; Benhamou CL
    Obstet Gynecol; 2009 Nov; 114(5):999-1007. PubMed ID: 20168099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-utility analysis of antibiotic treatment in patients with chronic low back pain and Modic changes: results from a randomised, placebo-controlled trial in Norway (the AIM study).
    Grotle M; Bråten LC; Brox JI; Espeland A; Zolic-Karlsson Z; Munk Killingmo R; Tingulstad A; Grøvle L; Froholdt A; Kristoffersen PM; Wigemyr M; van Tulder MW; Storheim K; Zwart JA;
    BMJ Open; 2020 Jun; 10(6):e035461. PubMed ID: 32546490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2.
    Aitken D; Laslett LL; Cai G; Hill C; March L; Wluka AE; Wang Y; Blizzard L; Cicuttini F; Jones G
    BMC Musculoskelet Disord; 2018 Jul; 19(1):217. PubMed ID: 30021646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.
    Westin JR; Thompson MA; Cataldo VD; Fayad LE; Fowler N; Fanale MA; Neelapu S; Samaniego F; Romaguera J; Shah J; McLaughlin P; Pro B; Kwak LW; Sanjorjo P; Murphy WA; Jimenez C; Toth B; Dong W; Hagemeister FB
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):99-105. PubMed ID: 23276888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic low back pain in relation to Modic changes, bony endplate lesions, and disc degeneration in a prospective MRI study.
    Luoma K; Vehmas T; Kerttula L; Grönblad M; Rinne E
    Eur Spine J; 2016 Sep; 25(9):2873-81. PubMed ID: 27480265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
    Silverman SL; Kriegman A; Goncalves J; Kianifard F; Carlson T; Leary E
    Osteoporos Int; 2011 Aug; 22(8):2337-45. PubMed ID: 21116816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Modic Changes and Low Back Pain in Middle Age: A Northern Finland Birth Cohort Study.
    Saukkonen J; Määttä J; Oura P; Kyllönen E; Tervonen O; Niinimäki J; Auvinen J; Karppinen J
    Spine (Phila Pa 1976); 2020 Oct; 45(19):1360-1367. PubMed ID: 32341297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.
    Hershman DL; McMahon DJ; Crew KD; Cremers S; Irani D; Cucchiara G; Brafman L; Shane E
    J Clin Oncol; 2008 Oct; 26(29):4739-45. PubMed ID: 18711172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis.
    Sheedy KC; Camara MI; Camacho PM
    Endocr Pract; 2015 Mar; 21(3):275-9. PubMed ID: 25370317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer.
    Leal T; Tevaarwerk A; Love R; Stewart J; Binkley N; Eickhoff J; Parrot B; Mulkerin D
    Clin Breast Cancer; 2010 Dec; 10(6):471-6. PubMed ID: 21147691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial.
    Pallay RM; Seger W; Adler JL; Ettlinger RE; Quaidoo EA; Lipetz R; O'Brien K; Mucciola L; Skalky CS; Petruschke RA; Bohidar NR; Geba GP
    Scand J Rheumatol; 2004; 33(4):257-66. PubMed ID: 15370723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hybrid Bone Single Photon Emission Computed Tomography Imaging in Evaluation of Chronic Low Back Pain: Correlation with Modic Changes and Degenerative Disc Disease.
    Russo VM; Dhawan RT; Dharmarajah N; Baudracco I; Lazzarino AI; Casey AT
    World Neurosurg; 2017 Aug; 104():816-823. PubMed ID: 28377243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.
    Cleeland CS; Body JJ; Stopeck A; von Moos R; Fallowfield L; Mathias SD; Patrick DL; Clemons M; Tonkin K; Masuda N; Lipton A; de Boer R; Salvagni S; Oliveira CT; Qian Y; Jiang Q; Dansey R; Braun A; Chung K
    Cancer; 2013 Feb; 119(4):832-8. PubMed ID: 22951813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.
    Shapiro CL; Halabi S; Hars V; Archer L; Weckstein D; Kirshner J; Sikov W; Winer E; Burstein HJ; Hudis C; Isaacs C; Schilsky R; Paskett E
    Eur J Cancer; 2011 Mar; 47(5):683-9. PubMed ID: 21324674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
    Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis.
    Catalano A; Morabito N; Atteritano M; Basile G; Cucinotta D; Lasco A
    Calcif Tissue Int; 2012 Apr; 90(4):279-85. PubMed ID: 22350110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amoxicillin Did Not Reduce Modic Change Edema in Patients With Chronic Low Back Pain: Subgroup Analyses of a Randomised Trial (the AIM Study).
    Kristoffersen PM; Vetti N; Grøvle L; Brox JI; Haugli Bråten LC; Grotle M; Julsrud Haugen A; Rolfsen MP; Froholdt A; Skouen JS; Lutro O; Marchand GH; Anke A; Zwart JA; Storheim K; Assmus J; Espeland A
    Spine (Phila Pa 1976); 2023 Feb; 48(3):147-154. PubMed ID: 36223435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.